Kane Biotech, Inc. (KNBIF)
0.0201
0.00 (0.00%)
USD |
OTCM |
Jun 08, 16:00
Kane Biotech EPS Diluted (Quarterly) : -0.0029 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Edesa Biotech, Inc. | -0.4939 |
| ProMIS Neurosciences, Inc. | -1.263 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.5211M |
| Revenue (Quarterly) | 0.0315M |
| Total Expenses (Quarterly) | 0.5526M |
| Enterprise Value | 4.746M |
| Gross Profit Margin (Quarterly) | -53.02% |
| Profit Margin (Quarterly) | -1.65K% |
| Earnings Yield | -63.18% |
| Normalized Earnings Yield | -63.68 |